Gilead Announces SVR12 Rates From Three Phase 3 Studies Evaluating a Once-Daily Fixed-Dose Combination of Sofosbuvir and Ledipasvir for Genotype 1 Hepatitis C Patients
KANSAS CITY, Mo. — Hepatitis C is a liver-destroying virus that’s most common in baby boomers. Many got it years ago from IV drug use or unsafe sex. Now there’s a new drug to cure it.
FibroScan KCRI Introduces the region to a new medical technology that eliminates invasive procedures from liver disease diagnosis. If you're interested in having a FibroScan test, call 816-759-5274. Or click here to participate.
_________________________________________________________________________ Clinical Trial for Individuals with Fatty Liver Disease KCRI is conducting clinical trails of investigational medication. If you're interested in participating in fatty liver disease clinical trials, call 816-759-5274. Or click here to participate.
_________________________________________________________________________